Literature DB >> 22258360

Acquired encephalopathy associated with carnitine deficiency after cefditoren pivoxil administration.

Heyun Kim1, Kon Chu, Keun-Hwa Jung, Soon-Tae Lee, Jeong-Min Kim, Sang Kun Lee.   

Abstract

We describe a 47-year-old woman who presented with palinopsia and subacute altered mental change after cefditoren pivoxil administration. The patient showed characteristic clinical manifestations of hypocarnitinemia, which affected her state of consciousness and she had radiologic findings that revealed metabolic encephalopathy with cytotoxic edema in the right occipital area and intracranial hemorrhages in right occipital and left frontal areas. Follow-up imaging after oral carnitine supplementation demonstrated complete resolution of the bilateral frontal subcortical T2 high-intensity lesions. Carnitine deficiency due to cefditoren pivoxil treatment may present as metabolic encephalopathy in adults. This possibility should be considered with the differential diagnosis of encephalopathies, and carnitine levels should be checked in patients treated with cefditoren pivoxil.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22258360     DOI: 10.1007/s10072-012-0939-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  11 in total

1.  Subnormal carnitine levels and their correction in artificially fed patients from a neurological intensive care unit: a pilot study.

Authors:  J Schäfer; H Reichmann
Journal:  J Neurol       Date:  1990-06       Impact factor: 4.849

Review 2.  Carnitine deficiency disorders in children.

Authors:  Charles A Stanley
Journal:  Ann N Y Acad Sci       Date:  2004-11       Impact factor: 5.691

3.  Carnitine deficiency induced by pivampicillin and pivmecillinam therapy.

Authors:  E Holme; J Greter; C E Jacobson; S Lindstedt; I Nordin; B Kristiansson; U Jodal
Journal:  Lancet       Date:  1989-08-26       Impact factor: 79.321

4.  Alteration of ammonia and carnitine levels in short-term treatment with pivalic acid-containing prodrug.

Authors:  T Ito; N Sugiyama; M Kobayashi; K Kidouchi; T Itoh; O Uemura; K Sugiyama; H Togari
Journal:  Tohoku J Exp Med       Date:  1995-01       Impact factor: 1.848

5.  Determination of the reference range of endogenous plasma carnitines in healthy adults.

Authors:  Stephanie E Reuter; Allan M Evans; Donald H Chace; Gianfranco Fornasini
Journal:  Ann Clin Biochem       Date:  2008-09-09       Impact factor: 2.057

6.  Interaction between pivaloylcarnitine and L-carnitine transport into L6 cells overexpressing hOCTN2.

Authors:  Liliane Todesco; Michael Bodmer; Karin Vonwil; Daniel Häussinger; Stephan Krähenbühl
Journal:  Chem Biol Interact       Date:  2009-03-11       Impact factor: 5.192

Review 7.  Brain magnetic resonance in the diagnostic evaluation of mitochondrial encephalopathies.

Authors:  Maria Cristina Bianchi; Giuseppina Sgandurra; Michela Tosetti; Roberta Battini; Giovanni Cioni
Journal:  Biosci Rep       Date:  2007-06       Impact factor: 3.840

Review 8.  Role of carnitine esters in brain neuropathology.

Authors:  Ashraf Virmani; Zbigniew Binienda
Journal:  Mol Aspects Med       Date:  2004 Oct-Dec

9.  Plasma carnitine deficiency. Clinical observations in 51 pediatric patients.

Authors:  S C Winter; S Szabo-Aczel; C J Curry; H T Hutchinson; R Hogue; A Shug
Journal:  Am J Dis Child       Date:  1987-06

Review 10.  Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?

Authors:  Philippe E R Lheureux; Andrea Penaloza; Soheil Zahir; Mireille Gris
Journal:  Crit Care       Date:  2005-06-10       Impact factor: 9.097

View more
  5 in total

Review 1.  L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain.

Authors:  Gustavo C Ferreira; Mary C McKenna
Journal:  Neurochem Res       Date:  2017-05-16       Impact factor: 3.996

2.  Cefepime-Induced Encephalopathy: Could Carnitine Deficiency Contribute to Neurotoxicity?

Authors:  Francisco José Fernández-Fernández; Eugenia Ameneiros-Lago
Journal:  Neurohospitalist       Date:  2019-12-26

3.  Cefepime Induced Neurotoxicity Following A Regimen Dose-Adjusted for Renal Function: Case Report and Review of the Literature.

Authors:  Michael L Behal; Jenni K Thomas; Melissa L Thompson Bastin; Breanne M Mefford
Journal:  Hosp Pharm       Date:  2021-09-16

4.  Update on the clinical utility and optimal use of cefditoren.

Authors:  José Barberán; Lorenzo Aguilar; María-José Giménez
Journal:  Int J Gen Med       Date:  2012-05-21

5.  A newborn with seizures born to a mother diagnosed with primary carnitine deficiency.

Authors:  Si Chen; Yingying Hu; Yumei Huang; Yan Nan; Xiaojian Zhou; Shangqin Chen; Jin Lin; Zhenlang Lin
Journal:  BMC Pediatr       Date:  2019-03-18       Impact factor: 2.125

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.